TTrialPathMatch Me to Trials
← Back to trials
RecruitingOsteoarthritis (OA)LongevityWound Care

Registry of Outcomes of Dezawa MuseCells®

Eligible age

Up to 89 yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The goal of this observational study is to learn about the long-term effects of Dezawa MuseCells to treat various diseases. The Primary Goal: What is the short-term and long- term outcomes of Dezawa Musecells? Participants treated with Dezawa MuseCells as part of their regular medical care and will answer online survey questions about symptoms and clinical outcomes for 5 years.

Sponsor: MuseCell Innovations Pte LTD

You may qualify if…

  • ✓ 1. Received Dezawa MuseCells® as Part of Routine Clinical Care
  • ✓ 2. Patients ( and/or authorized representative) capable of providing informed consent and participating in long-term follow-up.
  • ✓ 3. Willingness to Complete Online Survey Assessments
  • ✓ 4. Participants must have reliable access to email or a mobile device and be willing to complete digital surveys at scheduled intervals over a 5-year period.
  • ✓ 5. Diagnosis of a Condition for Which Dezawa MuseCells® Were Administered Includes, but is not limited to, neurologic, musculoskeletal, cardiovascular, immunologic, and systemic degenerative conditions.
  • ✓ 6. Ability to Communicate in the Registry's Supported Language
  • ✓ 7. Participants must be able to read and respond to registry surveys in the designated study language.
  • ✓ 8. Enrollment Within 12 Months of MuseCell® Administration

You may not qualify if…

  • ✕ 1. Not Receive Dezawa MuseCells®-Individuals who have not been treated with Dezawa MuseCells® or received a counterfeit/non-licensed product cannot be included.
  • ✕ 2. Unable or Unwilling to Provide Informed Consent Includes individuals with cognitive impairment who lack a legally authorized representative willing to consent on their behalf.
  • ✕ 3. Inability to Participate in Long-Term Digital Follow-Up
  • ✕ 4. Concurrent Participation in an Interventional Clinical Trial Affecting Outcomes
  • ✕ 5. History of Malignancy Diagnosed Within the Past 12 Months
  • ✕ 6. Excludes patients with active or recently treated cancer unless their treating physician determines participation poses no additional safety concerns.
  • ✕ 7. Any Condition That, in the Investigator's Judgment, Would Compromise Data Quality
  • ✕ 8. Use of Non-Licensed or Counterfeit "Muse-like" Cells Ensures that registry data reflect outcomes of authentic Dezawa MuseCells® produced under licensed methods.

Where it's recruiting

Florida

North Palm Beach

Source: ClinicalTrials.gov · NCT07645989 · last updated 2026-06-12

Registry of Outcomes of Dezawa MuseCells® · TrialPath